SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Reports of layoffs in India and the Philippines, with termination notices citing a scaled-down business assignment, have sparked concern that Innodata may have lost or reduced a major client project. Traders are divided between that revenue-risk interpretation and the view that the cuts reflect efficiency or a shift to contract workers, with the uncertainty weighing on shares ahead of Q3 results.

The Home Depot, Inc. engages in the sale of building materials and home improvement products. Its products include building materials, home improvement products, lawn and garden products and décor products. The firm operates through the following geographical segments: U.S., Canada and Mexico. It offers home improvement installation services, and tool and rental equipment. The company was founded by Bernard Marcus, Arthur M. Blank, Kenneth Gerald Langone and Pat Farrah on June 29, 1978 and is headquartered at Atlanta, GA.

Home Depot, Inc.

A recent rebound that held near breakout levels has prompted bullish swing-trade setups and call buying ahead of earnings. Traders are watching for follow-through, while some remain cautious about weak housing demand and interest-rate sensitivity.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

Attention centers on ImmunityBios upcoming QUILT-2.005 Phase 3 topline readout of ANKTIVA plus BCG for first-line bladder cancer; the company has completed the database lock and says an sBLA filing is on track for Q4. Traders are largely optimistic about the potential label expansion, while also watching Q3 results and debating whether the clinical and commercial momentum will justify the bullish expectations.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is drawing attention after a sharp precious-metals selloff and a reported 52-week low, with traders citing Fed rate-hike expectations and possible forced liquidation as pressures. The community is split between calling gold a failed safe haven and viewing the decline as a buying opportunity, with some watching for support or a rebound.

World Liberty Financial (WLFI) is a cryptocurrency launched in 2025and operates on the Ethereum platform. World Liberty Financial has a current supply of 100,000,000,000 with 31,779,991,497 in circulation. The last known price of World Liberty Financial is 0.05007445 USD and is up 0.02 over the last 24 hours. It is currently trading on 491 active market(s) with $20,910,403.62 traded over the last 24 hours. More information can be found at https://www.worldlibertyfinancial.com/.

WorldFinancial

WLFI discussion centers on its prolonged weakness and concerns that Trump-family crypto monetization and potential token sales are weighing on sentiment. Bulls counter that a bank charter and USD1-related utility could support a rebound, though those catalysts are discussed largely as expectations, while skeptics see no near-term support.

ProShares Trust II - ProShares Ultra VIX Short-Term Futures ETF 1.5x Shares

ProShares Ultra VIX Short-Term Futures ETF

UVXY is drawing attention after a sharp gain alongside elevated volatility and unusually heavy call activity. Traders are split between treating the move as a hedge against market risk and expecting the volatility spike to fade, citing the funds tendency to decay over time.

NextDecade Corp. is a development company, which focuses on liquefied natural gas (LNG) export projects and associated pipelines. It develops and manages land-based and floating liquefied natural gas projects in the Gulf Coast with focus on the Rio Grande LNG. The company was founded by Kathleen Eishbrenner in 2010 and is headquartered in Houston, TX.

NextDecade Corporation

Traders are framing disruptions to Qatari and other Middle Eastern LNG supply, including shipping risks around the Strait of Hormuz, as a potential tailwind for U.S. exporters and future contracting leverage at NextDecades Rio Grande project. Skeptics note that NEXT has not yet begun production and remains exposed to construction, financing, and execution risks ahead of planned first LNG output in 2027.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

AXSM is drawing attention after a steep selloff as investors await Q3 results to gauge whether Auvelitys Alzheimers-agitation launch is translating into paid prescriptions and whether commercial spending is delaying profitability. Some traders believe sampling and long-term-care channels understate demand, while others point to sluggish visible prescription growth, managements silence and cash-burn concerns.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladocs Q3 update sparked a sharp rally as traders focused on stronger profitability and cash generation, while revenue remained under pressure and BetterHelp continued to weigh on the growth outlook. Bulls are debating whether the results mark a turnaround and could pressure short sellers; skeptics see unresolved growth and execution risks.

Mobileye Global, Inc. engages in the business of developing and deploying driver assistance systems and autonomous driving technologies and solutions. It operates under the Mobileye and Other segments. The company was founded by Amnon Shashua and Ziv Aviram in 1999 and is headquartered in Jerusalem, Israel.

Mobileye Global Inc - Ordinary Shares - Class A

MOBILEYE GLOBAL INC

Mobileyes quarterly results beat expectations and included a modest outlook increase, but the shares sold off sharply and reached a 52-week low. Traders disagree over whether the decline is excessive given the companys cash position and buyback, or justified by weak growth, reliance on an R&D grant, and concerns about competition and demand for higher-end driver-assistance systems.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Is H. B. Fuller (FUL) Up 1.8% Since Last Earnings Report?

H. B. Fuller (FUL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Why H. B. Fuller (FUL) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

H.B. Fuller Board Unanimously Rejects Second Unsolicited, Non-Binding Proposal for Building Adhesive Solutions Segment

H.B. Fuller Company (H.B. Fuller or the Company) (NYSE: FUL), the worlds largest pureplay adhesives company, today announced that following a thorough review supported by independent financial and legal advisors, its Board of Directors has unanimously rejected Ancoras second unsolicited...

H.B. Fuller Prices $850M Debt Offering to Fund AMS Acquisition

FUL prices $850M in senior notes to finance its AMS acquisition and refinance debt, with a 7.625% coupon and a key redemption condition tied to the deal.

H.B. Fuller Announces Pricing of $850 Million Debt Offering

H.B. Fuller Company (H.B. Fuller) (NYSE:FUL) announced today that it has priced an offering of $850 million aggregate principal amount of 7.625% new senior unsecured notes due 2034 (the Notes) at an issue price of 100% of the principal amount, in a private offering (the Notes Offering) that is...

H. B. Fuller (FUL) is a Top-Ranked Value Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Director Of H.B. Fuller Makes $100K Buy

On September 30, DANIEL FLORNESS, Director at H.B. Fuller (NYSE:FUL) executed a significant insider buy, as disclosed in the latest SEC filing.
What Happened: In a recent Form 4 filing with the U.S. Securities andread more...

Teresa Trangsrud Rasmussen's Recent Buy: Acquires $99K In H.B. Fuller Stock

It was revealed in a recent SEC filing that Teresa Trangsrud Rasmussen, Board Member at H.B. Fuller (NYSE:FUL) made a noteworthy insider purchase on September 30,.
What Happened: In a recent Form 4 filing with the U.S.read more...

Insider Move: THOMAS HANDLEY Invests $98K In H.B. Fuller Stock

A new SEC filing reveals that THOMAS HANDLEY, Board Member at H.B. Fuller (NYSE:FUL), made a notable insider purchase on September 30,.
What Happened: HANDLEY's recent move, as outlined in a Form 4 filing with theread more...

Board Member Of H.B. Fuller Makes $100K Buy

It was revealed in a recent SEC filing that Srilata Zaheer, Board Member at H.B. Fuller (NYSE:FUL) made a noteworthy insider purchase on September 30,.
What Happened: In a recent Form 4 filing with the U.S. Securitiesread more...

H.B. Fuller Co. engages in the manufacture and marketing of adhesives, sealants, and other chemical products. It operates through the following business segments: Hygiene, Health, and Consumable Adhesives, Engineering Adhesives, and Construction Adhesives. The Hygiene, Health, and Consumable Adhesives segment supplies adhesive products in the assembly, packaging, converting, nonwoven, hygiene, health and beauty, flexible packaging, graphic arts, and envelope markets. The Engineering Adhesives segment provides adhesives to the transportation, electronics, medical, clean energy, aerospace and defense, performance wood, insulating glass, textile, appliance, and heavy machinery markets. The Construction Adhesives segment manufactures adhesives, sealants, tapes, mortars, and grouts for construction activities. The company was founded by Harvey Benjamin Fuller in 1887 and is headquartered in St. Paul, MN.

H.B. Fuller Company

H.B. Fuller Sees $55M Synergy Potential From AMS Deal – But Investors Are Still Selling FUL Stock 

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>H.B. Fuller made a cash offer of £2.85 per share for Advanced Medical Solutions shareholders.</li><li>The company expects about $55 million in combined run-rate revenue and cost synergies by 2031.</li><li>AMS is also expected to increase H.B. Fuller’s annual revenue by roughly $300 million while creating revenue growth and EBITDA opportunities.</li></ul><p>H.B. Fuller (FUL), the world’s largest pure-play adhesives maker, on Thursday said it would acquire UK-based Advanced Medical Solutions Group Plc in a cash deal valued at £715 million&nbsp;(about $941.8 million).</p><p>At the time of writing, FUL stock was down over 6% in Thursday's premarket trading.</p><h2 class="st-heading-2"><strong>Why H.B. Fuller Is Buying AMS</strong></h2><p>H.B. Fuller, the Minnesota-based adhesive maker, said the acquisition of Advanced Medical Solutions (AMS) would broaden its portfolio and add a medical adhesives segment to its overall product offerings.</p><p>“We have long been clear that medical is a core strategic growth market for H.B. Fuller given its durable demand trends, high regulatory-based entry barriers, and margin profile. Accordingly, we have thoroughly analyzed this structurally scarce market to identify the most attractive assets and growth opportunities,” said Celeste Mastin, President and Chief Executive Officer at H.B. Fuller.</p><h2 class="st-heading-2"><strong>Why Does The Deal Matter To FUL?</strong></h2><p>The company said that the deal would grow its capabilities across tissue bonding adhesives, tapes and dressings, and formulated bio-surgicals segments and result in bringing its total addressable market to $95 billion from $80 billion.</p><p>H.B. Fuller will also be able to leverage AMS’s pan-European salesforce and create cross-selling opportunities for its current portfolio, while AMS can utilize H.B. Fuller’s U.S. infrastructure and distribution network of market leaders to accelerate U.S. penetration.</p><p>The firm noted that it expects to capture about $55 million in combined run-rate revenue and cost synergies by 2031. AMS is also expected to increase H.B. Fuller’s annual revenue by roughly $300 million while creating revenue growth and earnings before interest, taxes , depreciation and amortization (EBITDA) opportunities.&nbsp;&nbsp;</p><h2 class="st-heading-2"><strong>FUL - AMS&nbsp;Deal Contours</strong></h2><p>According to the proposed deal, each eligible AMS shareholder will get £2.85 per share in cash, implying a total enterprise value of £715 million. The transaction will be 100% financed through a committed financing, H.B. Fuller said.</p><p>The deal is expected to close by the end of this calendar year.</p><h2 class="st-heading-2"><strong>FUL Q2 Earnings Print</strong></h2><p>On Wednesday, H.B. Fuller reported second-quarter revenue of $950 million, ahead of analysts' expectations of $924 million, while adjusted earnings of $1.41 per share came in more than Wall Street estimates of $1.38, according to Fiscal.ai data.</p><h2 class="st-heading-2"><strong>What Retail Thinks Of FUL</strong></h2><p>On Stocktwits, retail sentiment surrounding the stock has remained ‘bullish’ amid ‘high’ message volumes in the past 24 hours.</p><p><a href="https://stocktwits.com/symbol/FUL">FUL stock</a> has gained over 7% so far this year.</p><p>(£1 = $1.32)</p><p>For updates and corrections, email newsroom[at]stocktwits[dot]com.</p><p>Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/ibm-sub-1nm-chip-technology-100-billion-transistors/cZ1GgODR7Qu">IBM Just Packed 100B Transistors Into A Fingernail-Sized Sub-1nm Chip — Is It Rewriting Moore's Law?</a></p>

In this photo illustration, the H.B. Fuller company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

The Acquisition of Advanced Medical Solutions would broaden H.B. Fuller’s product portfolio and add a medical adhesives segment to its overall product offerings.

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$49.70
Prev Close	$49.69
Open	$49.26
Dividend Yield	1.59%
50-Day Moving Average	$51.60
Beta	0.99
Avg. Volume	937,802.45
PE Ratio	13.84

52-Week High	$68.63
52-Week Low	$46.70
Market Capitalization	$2.68B
EPS (Annual)	$2.75
Price to Book	1.23
Revenue Per Employee	$489,237.89

Feed

News

Sentiment

Earnings

Fundamentals

Info

FUL Fundamentals